NCT00990080View on ClinicalTrials.gov

Interchangeability of Infanrix™ IPV/Hib and Pediacel® at 2,4 & 6 Months of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

January 31, 2011

Conditions
Infant Immunizations
Interventions
BIOLOGICAL

Pediacel® and Infanrix™-IPV/Hib

0.5 mL IM at 2,4 and 6 months of age

Trial Locations (2)

B3K 6R8

Canadian Center for Vaccinology, Halifax

H9H 4Y6

MUHC- Vaccine Study Centre, Pierrefonds

Sponsors
All Listed Sponsors
collaborator

IWK Health Centre

OTHER

collaborator

MCM Vaccines B.V.

INDUSTRY

lead

Dalhousie University

OTHER